Import substitution didn’t come to the rescue: Russian pharmacies are without Klimonorm.
A medication prescribed to females during the change of life has vanished from drugstores in Russia.
As learned by Ostrogono Novosti, numerous pharmacies have ceased selling Klimonorm, fabricated by the Czech pharmaceutical firm Zentiva. This therapeutic agent is implemented in hormone replacement therapy (HRT) and is recommended to alleviate menopausal symptoms.
Patrons informed Ostorozhno Novosti that they became aware of Klimonorm’s absence roughly six weeks prior. Presently, it is not accessible in Moscow, Vladimir, Kaliningrad, St. Petersburg, Voronezh, Tver, and other cities within Russia. Based on our information, Klimonorm is also absent from the websites of leading pharmacy e-commerce platforms.
“Existing without it [Klimonorm] is a nightmare. Numerous women are in need of hormone replacement therapy, and domestic alternatives generally don’t deliver in this sphere. Russian HRT medicines are inadequate,” express women who have been consuming Klimonorm for an extended duration.
Back in 2023, gynecologists signaled disruptions in Klimonorm’s delivery to Russia, yet the drug’s availability was rapidly reinstated.
Experts from the pharmaceutical sector elucidated to “Ostorozhno Novosti” that Klimonorm might have disappeared from Russia owing to logistical complications, such as delays at customs. They similarly did not dismiss the chance that the manufacturing facility itself may have encountered difficulties. Potential reasons encompass breakdowns on the production line, interruptions in the provision of the medicinal ingredient, and certification concerns (the lot may have failed the concluding quality check).
